Skip to main content
Clinical Trials/NCT04055103
NCT04055103
Completed
Not Applicable

Improving Quality Based on the Joint Registry

Leiden University Medical Center1 site in 1 country20 target enrollmentAugust 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Registries
Sponsor
Leiden University Medical Center
Enrollment
20
Locations
1
Primary Endpoint
Survival (yes/no)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Test whether an intervention, consisting of frequently feedback of performance outcomes and education will improve patient care, expressed in better functional outcomes, fewer complications and more quality improving interventions.

Detailed Description

A randomized controlled trial will be conducted where hospitals will be randomized to an early versus late group, stratified by teaching status as this might influence the time available for quality improvement. Randomization will be done using a computer generated randomization table in a 1:1 ratio. During the study only orthopedic surgeons performing THA and TKA will receive monthly feedback by email. The intervention will consist of the following components: * Monthly feedback of performance outcomes; * Education on how to use joint registry data for quality improvement; * Create awareness by sending monthly feedback about performance; education and by asking what improvement activities have been introduced; * Hospitals will be linked to hospital with opposite performance outcomes to exchange information and find areas for improvement. During the trial, the investigators will conduct monthly measurement on intermediate outcomes showing whether the intervention reaches the target group (process evaluation). The following measurements will take place: * Knowledge among orthopaedic surgeons on their recent performance and how that relates to others; * Number of quality improvement activities undertaken with the aim to improve the quality of care; * Planned improvement activities (e.g. record review to figure out why performance is not as good as in other centers) together with who is responsible and by which time; * Number of people attending the meetings, number of times a specific account has accessed the LROI site to ensure that information has reached the target group; * Survey among orthopaedic surgeons at the end of the intervention period on knowledge learned and the extent to which they think this is sustainable in daily practice. In addition, the investigators will compare the outcomes between the early and the late group to test the effectiveness of the intervention, using the appropriate regression techniques. In the second period the investigators will test the sustainability of this approach in daily practice by comparing the outcomes within the early group with the first period, and compare with the late group to test whether outcomes in the sustainability phase are similar as when actively supported.

Registry
clinicaltrials.gov
Start Date
August 1, 2019
End Date
May 31, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Leiden University Medical Center
Responsible Party
Principal Investigator
Principal Investigator

PerlaJMarang

Associate Professor

Leiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • All Dutch orthopedic clinics where hip- and knee replacement surgery is performed who agree to participate will be randomized.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Survival (yes/no)

Time Frame: 1 year follow-up during trial

Patient survival after HA/TKA surgery

Number of Complications

Time Frame: 1 year follow-up during trial

Number of complications

Composite outcome measure (Textbook Outcome)

Time Frame: 1 year follow-up during trial

Including: Survival; 1-year revision rate; Length-of-Stay and Readmission.

1-year revision rate (%)

Time Frame: 1 year follow-up during trial

Number of revisions performed within one year adjusted for patient characteristics

Readmission (yes/no)

Time Frame: 1 year follow-up during trial

Readmission within 30 days after discharge

Prolonged length-of stay (yes/no)

Time Frame: 1 year follow-up during trial

Prolonged length-of-stay in the overall upper quartile

Secondary Outcomes

  • Number of Quality Improvement Initiatives(1 year follow-up during trial)

Study Sites (1)

Loading locations...

Similar Trials